Active Targeting of Drugs to Tumor Using Magnetic Gold Nanocarriers - Fathy, Mohamed M.;Elbialy, Nihal S.
39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
20 °P sammeln
  • Broschiertes Buch

Treatment of approximately 50% of human cancers includes the use of chemotherapy. The major problem associated with chemotherapy is the inability to deliver pharmaceuticals to specific site of the body without inducing normal tissue toxicity. Latterly, Magnetic Targeted Drug delivery (MTD) has been used to improve the therapeutic performance of the chemotherapeutic agents and reduce the severe side effects associated with the conventional chemotherapy for malignant tumors. In this book, we were focused on designing biocompatible magnetic nanoparticles that can be used as a nanocarrier's candidate for MTD regimen.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Treatment of approximately 50% of human cancers includes the use of chemotherapy. The major problem associated with chemotherapy is the inability to deliver pharmaceuticals to specific site of the body without inducing normal tissue toxicity. Latterly, Magnetic Targeted Drug delivery (MTD) has been used to improve the therapeutic performance of the chemotherapeutic agents and reduce the severe side effects associated with the conventional chemotherapy for malignant tumors. In this book, we were focused on designing biocompatible magnetic nanoparticles that can be used as a nanocarrier's candidate for MTD regimen.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Mohmaed M. Fathy, PhD in molecular Biophysics, now, working as a lecturer at Department of Biophysics, Faculty of Science, Cairo University. Interested in researches concerning in preparation and modification of nanoparticles, to make them more suitable for industrial and biological applications by giving newly chemical and physical properties.